Haibo Lu

690 total citations
29 papers, 455 citations indexed

About

Haibo Lu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haibo Lu has authored 29 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haibo Lu's work include Genetic factors in colorectal cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Colorectal Cancer Surgical Treatments (4 papers). Haibo Lu is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Colorectal Cancer Surgical Treatments (4 papers). Haibo Lu collaborates with scholars based in China, United States and Germany. Haibo Lu's co-authors include Jie Lian, Wayne L. Hofstetter, Stephen G. Swisher, Jack A. Roth, Bingliang Fang, Shuhong Wu, John D. Minna, Bingbing Dai, Shumei Zhang and Yan Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Haibo Lu

26 papers receiving 451 citations

Peers

Haibo Lu
Lijuan Ding China
Tao Song China
Jia-Hong Chen Taiwan
Yang Ling China
Zeyu Zhang China
Songtao Lai China
Yuanjun Jiang China
Honghe Luo China
Lijuan Ding China
Haibo Lu
Citations per year, relative to Haibo Lu Haibo Lu (= 1×) peers Lijuan Ding

Countries citing papers authored by Haibo Lu

Since Specialization
Citations

This map shows the geographic impact of Haibo Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Lu more than expected).

Fields of papers citing papers by Haibo Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haibo Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Lu. The network helps show where Haibo Lu may publish in the future.

Co-authorship network of co-authors of Haibo Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Haibo Lu. A scholar is included among the top collaborators of Haibo Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haibo Lu. Haibo Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Zhixing, et al.. (2025). Integrative analysis of semaphorins family genes in colorectal cancer: implications for prognosis and immunotherapy. Frontiers in Immunology. 16. 1536545–1536545. 2 indexed citations
2.
Lian, Jie, et al.. (2025). The role of SPP1+TAMs in cancer: Impact on patient prognosis and future therapeutic targets. International Journal of Cancer. 157(9). 1763–1771. 1 indexed citations
3.
Lian, Jie, et al.. (2024). Clinical Implications of Naples Prognostic Score for Patients with Resected Cholangiocarcinoma: A Real-World Experience. Journal of Inflammation Research. Volume 17. 655–667. 10 indexed citations
4.
5.
6.
7.
Lian, Jie, et al.. (2023). Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?. Frontiers in Immunology. 14. 1120684–1120684. 24 indexed citations
8.
9.
Wang, Xin, et al.. (2023). Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer. European Journal of Surgical Oncology. 49(12). 107138–107138. 6 indexed citations
10.
Deng, Chunyu, Cheng Yang, Haibo Lu, et al.. (2023). Unraveling temporal and spatial biomarkers of epithelial-mesenchymal transition in colorectal cancer: insights into the crucial role of immunosuppressive cells. Journal of Translational Medicine. 21(1). 794–794. 12 indexed citations
11.
Lian, Jie, et al.. (2023). Survival rate of colorectal cancer in China: A systematic review and meta-analysis. Frontiers in Oncology. 13. 1033154–1033154. 23 indexed citations
12.
Lian, Jie, et al.. (2022). Real-world survival of colon cancer after radical surgery: A single-institutional retrospective analysis. Frontiers in Oncology. 12. 914076–914076. 16 indexed citations
13.
Lian, Jie, et al.. (2022). Intrinsic resistance and efficacy of immunotherapy in microsatellite instability-high colorectal cancer: A systematic review and meta-analysis. SHILAP Revista de lepidopterología. 23(2). 198–208. 12 indexed citations
14.
Wang, Liru, Mu Su, Hongyan Zhao, et al.. (2021). Accurate Prediction of Prognosis by Integrating Clinical and Molecular Characteristics in Colon Cancer. Frontiers in Cell and Developmental Biology. 9. 664415–664415. 9 indexed citations
15.
Zhu, Jiang, Shumei Zhang, Xinxin Guo, et al.. (2018). Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis. International Journal of Surgery. 57. 76–83. 53 indexed citations
16.
Gao, Wen, Michael Wang, Li Wang, et al.. (2014). Selective Antitumor Activity of Ibrutinib in EGFR-Mutant Non–Small Cell Lung Cancer Cells. JNCI Journal of the National Cancer Institute. 106(9). 72 indexed citations
17.
Lu, Haibo, Li Wang, Wen Gao, et al.. (2013). IGFBP2/FAK Pathway Is Causally Associated with Dasatinib Resistance in Non–Small Cell Lung Cancer Cells. Molecular Cancer Therapeutics. 12(12). 2864–2873. 52 indexed citations
18.
Guo, Chengcheng, Haibo Lu, Wen Gao, et al.. (2013). Insulin-Like Growth Factor Binding Protein-2 Level Is Increased in Blood of Lung Cancer Patients and Associated with Poor Survival. PLoS ONE. 8(9). e74973–e74973. 39 indexed citations
19.
Su, Li, et al.. (2013). [Observation on the efficacy of acupuncture at key acupoints combined with rehabilitation therapy for spasmodic hemiplegia after cerebral infarction].. PubMed. 33(5). 399–402. 9 indexed citations
20.
Wang, Penghua, et al.. (2012). The outcomes of toe amputations in diabetic patients: a 5-year follow-up study. Zhonghua neifenmi daixie zazhi. 28(3). 201–206. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lijuan Ding Breakdown of academic impact, for papers by Tao Song Breakdown of academic impact, for papers by Jia-Hong Chen Breakdown of academic impact, for papers by Yang Ling Breakdown of academic impact, for papers by Zeyu Zhang Breakdown of academic impact, for papers by Songtao Lai Breakdown of academic impact, for papers by Yuanjun Jiang Breakdown of academic impact, for papers by Honghe Luo
Rankless by CCL
2026